merk, pfizer, lily. >> the bottom panel is its relative performance, the stock to its peer group, the ibb. engi amgen peeked a year ago in august. since that peak, it's out performed the ibb and that's very important. meaning, it's a defensive a fai group. here is the actual chart itself on the long-term basis. again you can draw is the lines any way you want. my eye sees that. when you have a standoff. bears and bulls are very much matched off. a series of low or highs. people make the bet this is going to do this and that's what makes a market. i'll take the other side of that. i think the uptrade the coming based on how good the relative performance has been. soy want to zero in on this long-term wedge more immediately. here is base of the action of the past year and a half. here's our all-time high. went to about 17.81. let's draw some lines. no lines, lines. i think we're going to do it. i'm going to play for the past high at 181. sort of an offensive, defensive low beta name. >> that would be quite some upside. >> i do think we're in a world right now where it's hard to imagine

this stock is more parlayed with some of the lower beta names like pfizer lily. okay.op panel is amge nrn and the bottom to its peer group. it piqued at $81 in august. since that as it has gone down on an absolute basis, that's very important. it's a defensive name in a fairly aggressive group and that's going serve you well if one were to do this trade. here is the actual chart itself on the long-term basis my eye seeing that. i think we're going to resolve this. there are plenty of people that make the bet this is going to do this. i'll take the other side. i think the uptrade is coming based on how good the relative performance has been. here's the action. no lines, line, i think we're going to do it. sort after an offensive, defensive large low beta name. >> mike? >> so, i do think, to dan's point, we're in a world now where it's hard to imagine what the good news for any stock is going to be, but in some like the financial, i wonder whether there's a a lot of bad news baked in. i've seen the chart going sideways. going make a mildly bullish bet because it could in

this stock in particular is more correlated with some of the big lower beta names like merck, pfizer, lily. the bottom panel is its relative performance to its peer group. amgen 81 dollars in august. a year ago since that peak, as it has gone down on an absolute basis, it has outperformed the ibb and that is very important. meaning it's a defensive name within a fairly aggressive group. and i think that is going to serve you well if one were to do this trade. here is the actual chart itself on the long-term basis. you can draw the lines any way you want. my eye sees that and i think we are going to resolve this. keep in mind that when you have a standoff. bears and bulls are very much matched off. a series of high or lows or highs or lows. many people bet it's going to do this and that makes a market. i take the other side. i think the uptrade is coming based on how good the relative performance has been. i want to zero in on this long-term wedge more immediately. here is base of the action of the past year and a half. here is our all-time high. 181. again, let's draw some lines. so no lin